Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
national top stories
novartis
roche
3
×
san francisco top stories
boston blog main
boston top stories
fda
investing
medical devices
national
new york top stories
san francisco blog main
venture capital
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
billy dunn
biofourmis
biogen
biotech ipos
biovotion
bolt biotherapeutics
boston
boulder/denver blog main
What
patients
3
×
drug
new
advantages
analytics
approved
atrophy
bar
bio
biofourmis
brings
daily
data
devices
digital
employs
evrysdi
expect
fda
friday
gamble
globally
green
hauls
help
home
intended
lights
liquid
market
medco’s
medicine
million
mover
muscular
oral
payers
physicians
plan
pricing
Language
unset
3
×
Current search:
roche
×
patients
×
unset
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone